Walmart, which employs around 1.6 million workers in the U.S., is the latest large company to push back on its DEI policies.
Lisa Parker never thought she’d be living her life around dialysis treatments. Diagnosed with stage 4 kidney disease without ...
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback